It is the cache of http://ebioscholar.com/ojs/index.php/ijb/article/view/210. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

A FUNCTIONAL APPROACH ON NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN (NGAL) – LIPOCALIN FAMILY | Pavan Kumar Padarthi, Elangovan N* | International Journal of Bioassays

A FUNCTIONAL APPROACH ON NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN (NGAL) – LIPOCALIN FAMILY

Kowsalya R, Jagatheesh K, Pavan Kumar Padarthi, Elangovan N*

Abstract


Lipocalins as biochemical markers of disease have been extensively used. The clinical indications relate to almost any field of medicine, such as inflammatory disease, cancer, lipid disorders, liver and kidney function. Lipocalins are mainly extracellular carriers of lipophilic molecules, though exceptions with properties like prostaglandin synthesis and protease inhibition are observed for specific lipocalins.  Lipocalin 2, a member of the lipocalin family that carries small lipophilic ligands, has gained recent attention as both a potential biomarker and a modulator of human cancers. Neutrophil gelatinase-associated lipocalin, also known as lipocalin 2, has been originally identified as a 25 kDa protein covalently linked to neutrophil gelatinase B. It is an acute phase protein involved in diverse physiological processes with an important role in intracellular iron transport. Moreover, lipocalin 2 is involved in the physiopathology of neoplastic process. Lipocalin 2 is a protein that has garnered a great deal of interest in multidisciplinary fields over the last two decades since its discovery. This review focuses on lipocalin 2 and its function.

Keywords


Lipocalins; Biomarker; Neutrophil Gelatinase Associated Lipocalin; Acute Phase Protein; Iron Transport-Cancer

Full Text:

PDF

References


Flower DR, The lipocalin protein family: structure and function, Biochem, 1996, 318, 1–14.

Yang J, Goetz D, Li JY, Wang W, Mori K, Setlik D, Du T, Erdjument-Bromage H, Tempst P, Strong R, Barasch J, An iron delivery pathway mediated by a lipocalin. Mol Cell, 2002, 10(5), 1045-1056.

Patel RC, Lange D, McConathy WJ, Patel YC, Patel SC, Probing the structure of the ligand binding cavity of lipocalins by fluorescence spectroscopy, Protein Eng, 1997, 10, 621–625.

Akerstrom B, Flower DR and Salier JP, Lipocalins: unity in diversity, Biochim. Biophys. Acta, 2002, 1482, 1–8.

Pervaiz S, and Brew K, Homology and structure function correlations between alpha 1-acid glycoprotein and serum retinol-binding protein and its relatives, FASEB J, 1987,1, 209–214.

Akerstrom B, Logdberg L, An intriguing member of the lipocalin protein family: alpha 1 microglobulin, Trends, Biochem. Sci, 1990, 15, 240 ± 243.

Cowan SW, Newcomer ME, Jones TA, Crystallographic refinement of human serum retinol binding protein at 2 A resolution, Proteins Struct Funct Genet, 1990, 8:44–61.

Flower DR, North ACT, Attwood TK, Mouse oncogene protein 24p3 is a member of the lipocalin protein family. Biochem Biophys Res Commun 1991, 180, 69–74.

Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N, Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase, J. Biol. Chem, 1993, 268, 10425–10432.

Xu SY, Carlson M, Engstrom AI, Garcia R, Peterson CGB, Venge P, Scand, The development of an assay for human neutrophil lipocalin (HNL) — to be used as a specific marker of neutrophil activity in vivo and vitro, J. Clin. Lab. Invest, 1994, 54: 365^376.

Triebel S, Blaser J, Reinke H, Tschesche H, A 25 kDa a2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase, FEBS Lett , 1992,314:386-388.

Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L, Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases, Gut, 1996, 38(3), 414–420.

Bundgaard JR, Sengelov H, Borregaard N, Kjeldsen L, Molecular cloning and expression of a cDNA encoding NGAL: a lipocalin expressed in human neutrophils, Biochem Biophys Res Comm, 1994, 202, 1468–75.

Cowland JB, Borregaard N, Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans, Genomics, 1997, 45,17–23.

Supervekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P, Differential gene expression following early renal ischemia/reperfusion, Kidney Int, 2003,63,1714–24.

Devireddy LR, Teodoro JG, Richard FA, Green MR, Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science, 2001, 293(5531), 829–834.

Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK, The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition, Mol Cell, 2002, 10(5), 1033-1043.

Devarajan P, Mishra J, Supavekin S, Patterson LT, Potter SS, Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery and novel therapeutics, Mol Genet Metab, 2003, 80, 365–76.

Stoesz SP, Heterogeneous expression of the lipocalin NGAL in primary breast cancers, Int J Cancer, 1998, 79, 565–572.

Furutani M, Arii S, Mizumoto M, Kato M, Imamura M, Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. Cancer Lett, 1998, 122, 209–214.

Bartsch S, Tschesche K, Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cells, FEBS Lett, 1995,357:255–259.

Flo TH, Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron, Nature, 2004 432:917–921.

Yan L, Borregaaard N, kjeldsen L, Moses MA, The high molecular weight urinary matrix metalloproteinase (MMP)activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 by NGAL, J BiolChem, 2001,276, 37258-37265.

Mishra J, Mori K, Ma Q, Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am SocNephrol, 2004, 15, 3073–82.

Kjeldsen L, Cowland JB, Borregaard N, Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse, BiochimBiophysActa, 2000, 1482, 272–83.

Kjeldsen L, Bainton DF, Sengelov H, Borregaard N, Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood, 1994, 83: 799-807.

Liu Q, Nilsen-Hamilton M, Identification of a new acute phase protein, J. Biol. Chem, 1995, 270, 22565 ± 22570.

Friedl A, Stoesz SP, Buckley P, Gould MN, Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression, Histochem, J, 1999, 31:433–441.

Sengelov H, Boulay F, Kjeldsen L, Borregaard N, Subcellular localization and translocation of the receptor for Nformylmethionyl-leucyl-phenylalanine in human. Biochem. J, 1994, 299,473 ± 479.

Holmes MA, Paulsene W, Jide X, Ratledge C, Strong RK, Siderocalin (Lcn 2) also binds carboxy mycobactins, potentially defending against mycobacterial infections through iron sequestration, Structure, 2005,13(1),29–41.

Nilsen-Hamilton M, Tissue involution and the acute phase response, Ann Acad Sci 2003, 995,94–108.

Ferna´ndez CA, Yan L, Louis G, The matrix metalloproteinase-9/neutrophil gelatinase associated lipocalin complex plays a role in breast tumor growth and is present in theurine of breast cancer patients, Clin Cancer Res, 2005,11:5390–5395.

Gruvberger S, Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns, Cancer Res, 2001, 61: 5979–5984.

Jones C, Expression profiling of purified normal human luminal and myoepithelial breast cells: Identification of novel prognostic markers for breast cancer. Cancer Res, 2004, 64, 3037–3045.

Taylor-Papadimitriou J, Lane EB In The Mammary Gland, Development, Regulation and Function, 1987, 181–215.

Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci, 2006, 103, 1834–1839.

Chan YR, Liu JS, Pociask DA, Zheng M, Mietzner TA, Berger T, Lipocalin 2 is required for pulmonary host defense against Klebsiella infection, J Immunol, 2009, 182, 4947–4956.

Iannetti A, Pacifico F, Acquaviva R, Lavorgna A, Crescenzi E, Vascotto C, The neutrophil gelatinase-associated lipocalin a NF-kappaB-regulated gene is a survival factor for thyroid neoplastic cells, ProcNatl Acad Sci, 2008,105,14058.


Refbacks

  • »
  • »
  • »
  • »
  • »
  • »


 

Int.J.Bioassays is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

Creative Commons License